摘要
目的了解降糖药的应用情况及趋势。方法对降糖药的品种、消耗量、销售金额、用药频度(DDDs)、日均费用(DDDc)进行综合分析。结果2004年至2006年降糖药单个品种的DDDc在逐年降低,但销售金额却在以每年大于7%的幅度递增,其中新型口服降糖药如胰岛素增敏剂和瑞格列奈的用量增长较快,胰岛素制剂中基因重组人胰岛素的增幅较大。结论降糖药是一类很有发展潜力的药物,胰岛素和新型口服降糖药的用量将不断增加。
Objective To study the applicational condition and development tendency of antidiabetic drugs. Methods To make the statistical analysis on amount of money,tendency and DDDs. Results Single variety＇s DDDc reduced year by year during the period 2004-2006. But the amount of money increased yearly by 7%. Among the total used drugs,the utilization of new oral drugs such as euglycemic agent and repaglinide increased quickly,genetic recombination insulin had fast amplification in insulin preparations. Conclusion Antidiabetic drugs have great potentiality of development. The quantities of insulin and new type of antidiabetic drugs for oral use will be increased continuously.
出处
《中国药业》
CAS
2008年第13期52-54,共3页
China Pharmaceuticals
